Jeryl L. Hilleman - 05 Jun 2025 Form 3 Insider Report for Omada Health, Inc. (OMDA)

Role
Director
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman
Issuer symbol
OMDA
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
3
Filing time
05 Jun 2025, 16:41:50 UTC
Previous filing
06 Jun 2025
Next filing
25 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HILLEMAN JERYL L Director C/O OMADA HEALTH, INC., 500 SANSOME STREET, SUITE 200, SAN FRANCISCO /s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman 05 Jun 2025 0001216628

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 50,000 $5.82 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 83,333 $6.81 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 16,666 $8.28 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 26,666 $6.06 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 21,666 $5.94 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 25,000 $10.44 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
F3 1/24th of the shares subject to the option vest on each monthly anniversary measured from June 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the second anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney